Education
About Us
Working with TipRanks
Follow Us
Eli Lilly & Co (LLY)
NYSE:LLY
LLY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$711.40 - $972.53
Previous CloseN/A
Volume1.27M
Average Volume (3M)3.62M
Market Cap
$872.91B
Enterprise Value$761.80B
Total Cash (Recent Filing)$3.27B
Total Debt (Recent Filing)$33.64B
Price to Earnings (P/E)78.6
Beta0.55
Next Earnings
May 01, 2025EPS Estimate
4.68Last Dividend Ex-Date
Feb 14, 2025Dividend Yield0.58%
Share Statistics
EPS (TTM)11.49
Shares Outstanding948,170,000
10 Day Avg. Volume3,670,585
30 Day Avg. Volume3,622,415
Financial Highlights & Ratios
PEG Ratio0.77
Price to Book (P/B)N/A
Price to Sales (P/S)19.38
Price to Cash Flow (P/CF)88.20
P/FCF Ratio223.20
Enterprise Value/Market Cap0.87
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit20.80
Enterprise Value/Ebitda48.75
Forecast
1Y Price Target
$1,029.14Price Target Upside12.96% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering18
---
Bulls Say, Bears Say
Bulls Say
Market ShareLilly continues to outgrow Novo with market share stretching towards equal.
Product GrowthMounjaro is steadily growing with a 4-week year-over-year growth rate at 61% vs 55% last week.
Bears Say
Market PenetrationZepbound vials make up a low/mid-single-digit percentage of total scripts, signaling limited market penetration.
---
Ownership Overview
10.33% Insiders
22.65% Mutual Funds
27.58% Other Institutional Investors
23.58% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LLY FAQ
What was Eli Lilly & Co’s price range in the past 12 months?
Eli Lilly & Co lowest stock price was $711.40 and its highest was $972.53 in the past 12 months.
What is Eli Lilly & Co’s market cap?
Eli Lilly & Co’s market cap is $872.91B.
When is Eli Lilly & Co’s upcoming earnings report date?
Eli Lilly & Co’s upcoming earnings report date is May 01, 2025 which is in 57 days.
How were Eli Lilly & Co’s earnings last quarter?
Eli Lilly & Co released its earnings results on Feb 06, 2025. The company reported $5.32 earnings per share for the quarter, beating the consensus estimate of $5.045 by $0.275.
Is Eli Lilly & Co overvalued?
According to Wall Street analysts Eli Lilly & Co’s price is currently Undervalued.
Does Eli Lilly & Co pay dividends?
Eli Lilly & Co pays a Quarterly dividend of $1.5 which represents an annual dividend yield of 0.58%. See more information on Eli Lilly & Co dividends here
What is Eli Lilly & Co’s EPS estimate?
Eli Lilly & Co’s EPS estimate is 4.68.
How many shares outstanding does Eli Lilly & Co have?
Eli Lilly & Co has 948,170,000 shares outstanding.
What happened to Eli Lilly & Co’s price movement after its last earnings report?
Eli Lilly & Co reported an EPS of $5.32 in its last earnings report, beating expectations of $5.045. Following the earnings report the stock price went up 3.347%.
Which hedge fund is a major shareholder of Eli Lilly & Co?
Currently, no hedge funds are holding shares in LLY
---
Eli Lilly & Co Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$1,029.14 (12.96% Upside)
$1,029.14 (12.96% Upside)
Blogger Sentiment
Bullish
LLY Sentiment 85%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 644.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.2B over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.1%
Last 30 Days ▼ 0.4%
Last 30 Days ▼ 0.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
19.64%
12-Months-Change
Fundamentals
Return on Equity
73.95%
Trailing 12-Months
Asset Growth
22.98%
Trailing 12-Months
Company Description
Eli Lilly & Co
Eli Lilly & Co (LLY) is a global pharmaceutical company that discovers, develops, manufactures, and markets products in human health. The company focuses on several key therapeutic areas, including diabetes, oncology, immunology, neurodegeneration, and pain management. With a robust portfolio of innovative medicines, Eli Lilly aims to improve patient outcomes and address unmet medical needs worldwide.
---
LLY Company Deck
---
LLY Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth and successful product launches, underpinned by strategic investments and advancements in the pipeline. However, challenges such as pricing pressures, a decline in Trulicity revenue, and supply constraints in certain regions tempered the overall positive outlook.Read More>---
LLY Revenue Breakdown
67.44% U.S.
15.36% Europe
9.48% ROW
4.03% Japan
3.69% China
---
LLY Stock 12 Month Forecast
Average Price Target
$1,029.14
▲(12.96% Upside)
Technical Analysis
Best Analysts Covering LLY
1 Year
1 Year Success Rate
36/36 ratings generated profit
1 Year Average Return
+49.32%
reiterated a buy rating 9 days ago
Copying Evan Seigerman's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +49.32% per trade.
---